Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

KALVKALV
10 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in KALVISTA PHARMACEUTICALS INC

WELLINGTON MANAGEMENT GROUP LLP previously held 0 shares of KALV (KALVISTA PHARMACEUTICALS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$941,269

Total Shares Change

-79,365

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$27.00
0
2026-Q1
Decreased
107,262
-12.3%
$2.2M0.0%$15.61
0
2025-Q4
Decreased
122,379
-2.9%
$2M0.0%$15.68
0
2025-Q3
Decreased
126,052
-5.2%
$1.5M0.0%$12.21
0
2025-Q2
Increased
132,900
+5.3%
$1.5M0.0%$11.41
27
2025-Q1
Increased
126,268
+2.8%
$1.5M0.0%$11.93
26
2024-Q4
Increased
122,863
+4.2%
$1M0.0%$8.39
26
2024-Q3
Increased
117,923
+40.4%
$1.4M0.0%$12.34
34
2024-Q2
Increased
84,023
+5.9%
$989,7910.0%$11.78
27
2024-Q1
New
79,365
-
$941,2690.0%$11.86
35

Other major holders of KALV: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used